Last updated on July 2009

Alzheimers? Be a Part of Research.


Brief description of study

Alzheimers? Be a Part of Research.

Detailed Study Description

This study is for participants that have been diagnosed with a mild to moderate form of Alzheimer's disease (AD). This research involves an experimental study drug known as LY2062430. The primary objective of this study is to test whether LY2062430 will slow the rate of mental (thinking and remembering) decline of Alzheimer's disease as compared with placebo (a substance that looks like the study drug, but has no medicine).

Qualified Participants Must: Be diagnosed with a mild to moderate form of Alzheimer's disease; Have a reliable caregiver who is in frequent contact with you; Have good veins

Qualified Participants Will Receive: $50 per completed study visit.

Clinical Study Identifier: TX134506

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.